key: cord-0957411-6e9lnn1i authors: Lima, Maria; Siokas, Vasileios; Aloizou, Athina-Maria; Liampas, Ioannis; Mentis, Alexios-Fotios A.; Tsouris, Zisis; Papadimitriou, Anastasios; Mitsias, Panayiotis D.; Tsatsakis, Aristidis; Bogdanos, Dimitrios P.; Baloyannis, Stavros J.; Dardiotis, Efthimios title: Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System date: 2020-09-25 journal: Curr Treat Options Neurol DOI: 10.1007/s11940-020-00647-z sha: 322722dbf3ccc52edd65c9b3ab136ff62c27c92a doc_id: 957411 cord_uid: 6e9lnn1i PURPOSE OF REVIEW: To describe the possible neuroinvasion pathways of Severe Acute Respiratory Syndrome-related Coronavirus-2 (SARS-CoV-2), the virus responsible for the Coronavirus disease-19 (Covid-19) pandemic. RECENT FINDINGS: We present data regarding the family of Coronaviruses (CoVs) and the central nervous system (CNS), and describe parallels between SARS-CoV-2 and other members of the family, which have been investigated in more depth and combine these findings with the recent advancements regarding SARS-CoV-2. SUMMARY: SARS-CoV-2 like other CoVs is neuroinvasive, neurotropic and neurovirulent. Two main pathways of CNS penetration seem to be the strongest candidates, the hematogenous and the neuronal. Τhe olfactory route in particular appears to play a significant role in neuroinvasion of coronaviruses and SARS-CoV-2, as well. However, existing data suggest that other routes, involving the nasal epithelium in general, lymphatic tissue and the CSF may also play roles in SARS-CoV-2 invasion into the CNS. Coronaviruses (CoVs) are a large family of viruses, capable of infecting many species of birds and mammals [1] [2] [3] . There are seven coronaviruses known to infect humans, called human coronaviruses (HCoVs) [4] [5] [6] . Clinically, infection with a coronavirus can be either asymptomatic or present with respiratory, gastrointestinal (GI), and neurological symptoms [7] . Four HCoVs, namely 229E, OC43, HKU1, NL63, are not considered to be very pathogenic [8, 9] , while the rest, Severe Acute Respiratory Syndrome-related Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome-related Coronavirus (MERS-CoV) have caused two epidemics so far [8, [10] [11] [12] , and the novel SARS-CoV-2 caused the current pandemic [13] [14] [15] [16] ; all these viral strands can lead to acute respiratory failure. In this review, we aim to shed some light into how this novel virus can impact the central nervous system (CNS) by describing the routes of its invasion into the CNS. Many studies have shown that coronaviruses are neuroinvasive, neurotropic, and neurovirulent in animals and humans [17] [18] [19] [20] [21] [22] . In animals, the mouse hepatitis virus (MHV), a member of the coronavirus family, can infect microglia and astrocytes [23] , as well as Koppler cells at choroid plexuses; a systemic model of infection with SARS-CoV showed that the virus reached the brain [24] . It has also been reported that human coronaviruses have the ability to infect primary cultures of human neural cells, fetal and adult astrocytes, adult microglia and adult oligodendrocytes [25] [26] [27] . [ Fig. 1 ]. The detection of HCoVs in human CNS samples was described in the early 1980s, in autopsy tissues of patients with Multiple Sclerosis (MS) [28] . RNA from endemic prototype HCoV strains OC43 and 229E has also been detected in human brain samples [19] , and can persist over time [29] . Neurological manifestations have also been described in the symptom constellation of the two previous epidemics of MERS- [30, 31] and SARS-CoV [32] , where the virus was also detected in cerebrospinal fluid (CSF) [21, 32, 33] . More specifically, it was shown that SARS-CoV could induce cerebral edema and meningeal vasodilation [34] , neuronal morphological changes in the cortex and hypothalamus [35] , neuronal ischemic lesions and necrosis, glial hyperplasia [36] and demyelination, while its genome sequences (viral particles) have also been detected in brain samples of infected patients [34] [35] [36] [37] [38] [39] [40] [41] . Consequently, it comes as no surprise that a SARS-CoV-2 infection may present with neurological manifestations and CNS symptoms at high rates [42, 43] , such as headache, confusion [44] and sensory disturbances, namely anosmia and ageusia [42•] . Additionally, entities such as encephalitis [45] , acute cerebrovascular diseases [42, 46] , acute necrotizing encephalopathy (ANE) [47] , as well as demyelination and neuropathy [22] have also been reported in the current pandemic. Furthermore, the presence of SARS-CoV-2 has been established in the CSF of patients with acute neurologic symptoms, like seizures [48, 49] or encephalitis [45] , at times combined with MRI findings pertaining to the condition at hand [48•] . Post-mortem examination of SARS-CoV-2-infected patients revealed the presence of SARS-CoV-2 in endothelial cells and pericytes of brain capillaries [50•] and neurons [50, 51] , further confirming the presence of SARS-CoV-2 in the CNS. It has also been postulated that the presence of the virus in areas of the medulla, and the cardiorespiratory center in particular, may be one of the likely causes of COVID-19's respiratory failure [22, 52] . It was quickly established that SARS-CoV-2 binds to the receptor of the Angiotensin Converting Enzyme 2 (ACE2) with higher affinity than the other HCoVs, due to Curr Treat Options Neurol (2020) 22:37 some structural differences in its "Receptor Binding Domain" of the S spike protein (S) [15, 53, 54] . Receptors of ACE2 exist in almost all human organs [55, 56] , as well as in endothelial cells [52] and the CNS [55] [ Fig. 2 ]. As such, it is highly likely that SARS-CoV-2, similarly to SARS-CoV [57, 58] , makes use of these receptors in order to penetrate these tissues and trigger the perpetuation of immune responses [59] or finally invade the CNS, via the different pathways that we describe below. The HEMATOGENOUS pathway Viremia Viremia follows the primary infection, and is the phase when most neurotropic viruses are present into the bloodstream, where they possibly stay for a period of time, before they finally reach the CNS [60] . Although HCoVs seem to mainly infect the respiratory tract and be self-restricting, they can potentially disrupt the epithelium barrier and invade the bloodstream [18] . Type II alveolar epithelial cells, which highly express ACE2, are the cells mainly infected by SARS-CoVs [39] , thus allowing entrance of the virus to the blood circulation. Another possible pathway to the blood circulation could be through the epithelial cells of the GI tract [59] , which also express ACE2 receptors and can be infected by SARS-CoV-2 [61] [62] [63] . While other pathways cannot be excluded, passage through the respiratory tract is the most plausible scenario. Once in the blood circulation, SARS-CoV-2 could bind to the ACE2 receptors of the endothelium [50, 52, 55] and disrupt the Blood Brain Barrier (BBB), inducing edema, intracranial hypertension and/or penetration of the virus in the CNS [64, 65] . Neuroinvasion has been described for other coronaviruses in the past [29, 66] . In greater detail, Cabirac et al. (1993) showed that intravenous (IV) inoculation with MHV in owl monkeys led to brain and spinal cord infection, with the presence of viral RNA and/or antigen in the brain sites of inflammation, the blood vessels, and the endothelium [67] . Additionally, MERS-CoV can access the bloodstream, subsequently infecting endothelial cells in vivo [68] . Finally, Paniz-Mondolfi et al., (2020) observed viral-like particles of SARS-CoV-2 in the endothelial cells and pericytes of brain capillaries as well as astrocytic processes, which actively overrode the BBB [50•], strongly supporting a hematogenousendothelial neuroinvasion-based hypothesis for SARS-CoV-2. In a similar way, it can be postulated that SARS-CoV-2 could also infect the endothelial cells of the blood-cerebrospinal fluid barrier (BCSFB), and then spread into the CNS. Moreover, the choroid plexus and the circumventricular cerebral organs are not protected by the BBB, and could thus be gates for the penetration of a virus into the CNS [69] . SARS-CoV-2 could also enter the CNS under conditions promoting an increase of the permeability of the BBB, as a result of the release of inflammatory mediators (chemokines, cytokines) [70] , and even a cytokine storm, following inflammation or hypoxemia induced by the respiratory distress syndrome, or even psychological stress [59, [71] [72] [73] . This paracellular transmigration pathway is mainly mediated by the destabilization or disruption of the tight junctions of the BBB [69] . Peripheral immune cell transmigration -the "trojan horse" mechanism SARS-CoV-2 could also infect bloodstream leukocytes (mainly monocytes/ macrophages) [65] and myeloid cells, which become a viral pool for the diffusion of the virus towards the CNS [69, 74, 75] . SARS-CoV can infect lymphocytes and monocytes near the vessel wall [34, 35, 38] and seems to use this "Trojan Horse" mechanism [18, 76] . Other coronaviruses present similar abilities; MHV can infect macrophages [23] , while HCoV-OC43 and HCoV-229E can infect human monocytes/macrophages [76, 77] . In addition, HCoV-229E was able to infect murine and human dendritic cells in vitro [78] , which express the human aminopeptidase N (CD13) leading to their subsequent activation [79] . SARS-CoV is also speculated to have as a binding receptor, the human CD13 [80] . It has been shown to infect immune cells, monocytes, macrophages and T lymphocytes in particular, which are consistently reduced in these patients (lymphopenia), even at early disease stages [35] , something that has been reported for SARS-CoV-2 patients as well [42•] . Thus, we can hypothesize that SARS-CoV-2 uses immune circulating cells [42•] and dendritic cells to disseminate into other tissues and the CNS. It is possible that monocytes/macrophages could also be a "future" source of SARS-CoV-2, as is the case of other HCoVs [19] , since the infection of these leukocytic cell lines can persist over time [76] . Another possible pathway for the penetration into the CNS for SARS-CoV-2 could be the neuronal pathway. Some viruses can invade from the nerve "ending", i.e. the peripheral nerves [64, 81] . However, some viruses can invade from the nerve "ending", i.e. the peripheral nerves [81] , and by the mechanism of active transport within the neurons, more specifically through the motor proteins kinesin and dynein [69] , and via microtubules, travel in a retrograde way and reach the CNS [82] . These neurons could be motor, sensory or autonomic neurons, but are most often olfactory neurons [69, 81, 83] . Τhere is growing evidence that CoVs may initially infect peripheral nerve endings and then enter the CNS through a synapse-connected route [84] [85] [86] . This trans-synaptic transmission has been well documented for some CoVs, such as HEV67 [84, 85, 87, 88] . There is also data supporting the notion that HCoV-OC43 might also penetrate the CNS through cranial peripheral nerves [40] , as occurs with other respiratory viruses [respiratory syncytial virus (RSV) and influenza virus] [81] . Dubé et.al (2018) showed that viral particles could be passively released/diffused or transported via axonal transport (neuron-toneuron) by axoplasmic flow in cell cultures [40] . It also appears that neurons are very sensitive to SARS-CoV infection, due to their host cell receptors [39] . More specifically, the S1 unit of the S protein of the virus binds to ACE2 receptor of the neuron and with the action of the serine protease transmembrane protease, serine 2 (TMPRSS2) activates the S protein, that allows the virus to invade the neuron [89] . The olfactory pathway is an excellent neuronal pathway for neuroinvasive respiratory viruses [81] that access the body intranasally [64] , as the olfactory nerve communicates both with the nasal epithelium and the olfactory bulb [64, 69] . This pathway seems to be one possible mechanism of neuroinvasion for coronaviruses, including SARS-CoV-2 [39, 90, 91] . In animal models, intranasal inhalation of CoVs can lead to cerebral infection. For example, MHV induced infection in mice, and its RNA was detected in brain and muscles [92] . HCoV-OC43 also invades the CNS via the neuroepithelium and starts neuropropagation at the olfactory bulbs [40, 92, 93] . It has been reported that 3 days after nasal inoculation in mice, viral antigens of HCoV-OC43 can be found in the olfactory bulb [both in the olfactory sensory neurons (OSN) and in dendrites-associated cilia [40] ] while no virus is found in perivascular blood cells or other CNS sites [93] . The virus then has the ability to reach highly susceptible regions of the cortex, the mesolimbic cortex or other areas associated with olfaction [40] , such as the hippocampus and the amygdala, and finally through trans-neuronal propagation, it may reach the brainstem and the spinal cord [94] . The virus can be detected in the entirety of the brain just 7 days after the nasal inoculation, suggesting a relatively rapid dissemination once it invades the CNS, leading to acute encephalitis and death [93] . Moreover, ablation of the olfactory bulb after nasal infection of MHV blocked the spread [95] , strongly supporting the olfactory pathway dissemination theory. SARS-CoV, which is homologous to SARS-CoV-2, was also detected in the CNS of susceptible mice after intranasal infection, showing its neuroinvasive capabilities [39, 73] . More specifically, Netland et al. (2008) detected SARS-CoV in the olfactory bulb of mice approximately 3 days after nasal inhalation, and in the mesolimbic cortex only 1 day later, in addition to other brain regions and the brainstem, invading almost the entirety of the brain [39] . SARS-CoV-2 might also be transferred to the CNS through the trigeminal nerve, which innervates nociceptive cells in the nasal cavity, and has been successfully tested for drug transportation [96, 97] . Sensory nerve endings of the trigeminal nerve also exist in the conjunctiva, where SARS-CoV-2 RNA fragments have been found in a patient with conjunctivitis [98] , and in the taste buds, ascending not only in trigeminal nuclei, but also to the nuclei of the solitary tract [59] . It has been demonstrated that some viruses, such as influenza, can enter the CNS via the sensory fiber of the vagus nerve in the respiratory tract [81, 86, [99] [100] [101] . This also represents another communication route between the emesis center, the vagus nerve and the GI tract, which may play a role in this retrograde penetration of the SARS-CoV-2 to the CNS [59] . In addition, local peripheral nerves from the GI system might be infected, as SARS-CoV-2 also infects the GI tract [61] [62] [63] . As noted above, many researchers have demonstrated that the brain stem is an area that is particularly infected by SARS-CoV [39, 73] and MERS-CoV [91] ; this adds support to the notion that through trans-synaptic transmission, SARS-CoV-2 might also infect the brainstem from the respiratory system [52] . However, no direct proof that SARS-CoV-2 and HCoVs use the vagus nerve for neuroinvasive purposes has been published [59] . It is worth mentioning that dyspnea may stem from the primary CNS infection, mainly through the olfactory mechanism that leads to the brainstem, where the stem nuclei and the solitary tract are connected to the respiratory system [52, 102] . Netland et al. (2008) demonstrated that the main gate of SARS-CoV infection in mice was the olfactory pathway and could lead to death. However, the presence of the virus in lungs was low suggesting that infected neurons in the medulla and the cardiorespiratory center were responsible for this outcome [39] . This scenario proposes that direct infection of the CNS might be the primary gate of the virus in the organism [39, 52] . Additionally, postmortem examination of SARS-CoV patients detected viral particles in the brain almost exclusively in neurons, rather than in glia [34] [35] [36] , adding more support to the neuronal rather than the hematogenous pathway. A recent study found that the genes for ACE2 receptors and TMPRSS2, responsible for the binding of SARS-CoV-2, are expressed in the olfactory epithelial support and stem cells, but not in the olfactory sensory neurons (OSN) of mice and humans [103] . It has also been demonstrated that nasal inoculation of HCoV-229E to human volunteers disrupted the nasal epithelium, damaging and decreasing the number of the ciliated cells [104] . Perineural spaces of olfactory nerves and the nasal lymphatic tissue are important for drainage of the CSF, as they communicate with the CSF through channels made by the ensheathing cells [105, 106] . That means that the nasal olfactory epithelium and its lymphatic tissue may contribute to SARS-CoV-2 neuroinvasion in another indirect pathway. Lymphatic endothelial cells express receptors of CD209L, another receptor for SARS-CoVs, with lower affinity than ACE2 that is expressed mainly in lymphatic and liver tissues [107, 108] . It has been described that human hilar and mesenteric lymph nodes can be invaded by SARS-CoV [109, 110] . It is not unreasonable to hypothesize that other lymphatic networks, like those in oral tissues [111] or in the ocular mucosa [112] could be targets for SARS-CoV-2. Following this train of thought, the case of a patient presenting with seizures and SARS-CoV-2 in the CSF, 10 days after conjunctivitis [49] , demonstrates possible neuroinvasion through the conjunctiva. According to this theory, viremia could be the sequela of infection of lymphatic tissue in the affected organ, such as the respiratory or GI tract [18, 59] , leading to the neuroinvasion via the aforementioned hematogenous route. The CNS microenvironment following SARS-CoV-2 infection is presented at Fig. 3 [Fig. 3 ]. In an attempt to understand the possible mechanisms of SARS-CoV-2 neuroinvasion, it is reasonable to study the neuroinvasive behavior of known CoVs that have been studied for a longer period of time. The two basic common pathways for viral neuroinvasion that have been better described so far are hematogenous and neuronal. It has been demonstrated that coronaviruses can use either pathway to achieve CNS penetration. SARS-CoV-2 seems to not be an exception, as it shares common features with the other coronaviruses and can induce neurological symptoms. There are indications that SARS-CoV-2 can take advantage of both the hematogenous and neuronal routes, as it principally uses the ACE2 receptor that exists in circulatory and nervous systems. In addition, SARS-CoV-2 may also penetrate lymphatic tissues leading to entrance to the CNS. Based on the data presented in this review, the CNS may be affected by a subsequent effect of a primary systemic infection, through hematogenous or neuronal pathways. However, the CNS may also be the primary entry organ, infected mainly through the olfactory route, via which the virus enters the boby and spreads to other systems. In that case, the aforementioned "neurogenic hypothesis" is reinforced, and this invasion route could be particularly dangerous, as it could lead to the infection of the brainstem and the respiratory center, causing respiratory failure. More research is needed to confirm these hypotheses and will lead to more efficient therapeutic and preventive strategies. Fig. 3 . The CNS microenvironment following SARS-CoV-2 infection. Spread of SARS-CoV-2 from lungs to the CNS can most likely be achieved through the haematogenous route. In addition, it can enter the CNS through the olfactory bulb, and once the infectious agent persists due to the inability of the immune system to control/suppress viral replication, the virus may reach the whole brain and the CSF, and participate in demyelination. In the hematogenous route, SARS-CoV-2 may gain access by infecting endothelial cells of the blood-brain-barrier, epithelial cells of the blood-cerebrospinal fluid barrier in the choroid plexus, or it may indeed use inflammatory cells as "Trojan horse" to obtain access into the CNS. Experimental data suggest that primary glial cultures can secrete a series of inflammatory cytokines participating in the perpetuation of viral infection and further inflicting CNS tissue damage. The role of astrocytes in the machinery of SARS-CoV-2 mediated CNS pathology is yet undetermined and remains to be defined. particular interest, published recently, have been highlighted as: • Of importance Comprehensive analysis of drugs to treat Sars-Cov-2 infection: mechanistic insights into current Covid-19 therapies (review) Covid-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence Middle East respiratory syndrome coronavirus: another zoonotic Betacoronavirus causing Sars-like disease Towards effective Covid-19 vaccines: updates, perspectives and challenges (review) Obesity -a risk factor for increased Covid-19 prevalence, severity and lethality (review) Coronavirus infectionsmore than just the common cold Hosts and sources of endemic human coronaviruses Genomic analysis of 15 human coronaviruses Oc43 (Hcov-Oc43s) circulating in France from 2001 to 2013 reveals a high intra-specific diversity with new recombinant genotypes Editorial: nicotine and Sars-Cov-2: Covid-19 may be a disease of the nicotinic cholinergic system Covid-19 in northern Italy: an integrative overview of factors possibly influencing the sharp increase of the outbreak (review) possibility of transmission through dogs being a contributing factor to the extreme Covid-19 outbreak in North Italy A new threat from an old enemy: reemergence of coronavirus (review) Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding Phylogenetic analysis of SARS-CoV-2 showed that SARS-CoV-2 belongs to the subgenus of Sarbecovirus of the genus Betacoronavirus, with its closest relatives being two bat-coronaviruses, suggesting bats as the original host of the virus. Moreover, revealed that its receptorbinding domain structure is similar to that of SARS-CoV Sars-Cov-2, Sars-Cov, and Mers-Cov: a comparative overview A novel coronavirus from patients with pneumonia in China Inflammation in Neuroviral diseases Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses Neuroinvasion by human respiratory coronaviruses Coronaviruses post-Sars: update on replication and pathogenesis Possible central nervous system infection by Sars coronavirus Neurological manifestations of Covid-19 and other coronavirus infections: a systematic review Coronavirus infection of the central nervous system: host-virus stand-off Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (Sars-Cov) pulmonary infection of mice Infection of primary cultures of human neural cells by human coronaviruses 229e and Oc43 Viruses and multiple sclerosis: from mechanisms and pathways to translational research opportunities Viruses and endogenous retroviruses in multiple sclerosis: from correlation to causation Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients Brain invasion by mouse hepatitis virus depends on impairment of tight junctions and Beta interferon production in brain microvascular endothelial cells Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia Neurological complications during treatment of Middle East respiratory syndrome Detection of Sars coronavirus Rna in the cerebrospinal fluid of a patient with severe acute respiratory syndrome Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis Organ distribution of severe acute respiratory syndrome (Sars) associated coronavirus (Sars-Cov) in Sars patients: implications for pathogenesis and virus transmission pathways Multiple organ infection and the pathogenesis of Sars Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine Mig in pathogenesis Interferonmediated Immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome Detection of severe acute respiratory syndrome (Sars)-associated coronavirus Rna in autopsy tissues with in situ hybridization. Di Yi Jun Yi Da Xue Xue Bao Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human Ace2 Axonal Transport Enables Neuronto-Neuron Propagation of Human Coronavirus Oc43 Covid-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease One of the first reviews that reported neurological manifestations in Covid-19 patients, in retrospective, oservational case series, of the Union Hospital of Huazhong University of Science and Technology Zhang YY Diagnosis and Treatment Recommendations for Pediatric Respiratory Infection Caused by the 2019 Novel Coronavirus Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A Descriptive Study Nervous system involvement after infection with Covid-19 and other coronaviruses Clinical features of patients infected with 2019 novel coronavirus in Wuhan Reports the clinical, epidemiological, laboratory, and radiological features and clinical and treatment outcomes of the first covid-19 pneumonia cases in Wuhan Covid-19-associated acute hemorrhagic necrotizing encephalopathy: Ct and Mri features. Radiology A First Case of Meningitis/ Encephalitis Associated with Sars-Coronavirus-2 Reports one of the first case of meningitis associated with SARS-CoV-2 infection, detecting SARS-CoV-2 RNA in CSF, but not in the nasopharyngeal swab, and accompanied by MRI findings of meningitis First motor seizure as presenting symptom of Sars-Cov-2 infection Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus −2 (Sars-Cov-2) Reports the presence of SARS-CoV-2 in neural and capillary endothelial cells in brain tissue from postmortem examinations of a covid-19 patient, providing evidenve of its neuroinvasive and neurotropic capabillities. 51. Nath A. Neurologic complications of coronavirus infections The Neuroinvasive potential of Sars-Cov2 may play a role in the respiratory failure of Covid-19 patients Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of Sars Coronavirus Cryo-Em structure of the 2019-Ncov spike in the Prefusion conformation Tissue distribution of Ace2 protein, the functional receptor for Sars coronavirus. A first step in understanding Sars pathogenesis Single cell Rna sequencing of 13 human tissues identify cell types and receptors of human coronaviruses Angiotensin-converting enzyme 2 is a functional receptor for the Sars coronavirus Innate immune response of human alveolar type ii cells infected with severe acute respiratory syndromecoronavirus Neurological manifestations of patients with Covid-19: potential routes of Sars-Cov-2 Neuroinvasion from the periphery to the brain Molecular pathogenesis of neurotropic viral infections Clinical characteristics and intrauterine vertical transmission potential of Covid-19 infection in nine pregnant women: a retrospective review of medical records Review of the Clinical Characteristics of Coronavirus Disease 2019 (Covid-19) Evidence for Gastrointestinal Infection of Sars-Cov-2. Gastroenterology Virus infections in the nervous system Mechanism of West Nile virus Neuroinvasion: a critical appraisal Murine coronavirus Neuropathogenesis: determinants of virulence Coronavirus Jhm Omp1 pathogenesis in owl monkey Cns and coronavirus infection of owl monkey Cns via peripheral routes Emerging human Middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs Viral diseases of the central nervous system West Nile virus-induced disruption of the bloodbrain barrier in mice is characterized by the degradation of the Junctional complex proteins and increase in multiple matrix Metalloproteinases an inexpressible dread": psychoses of influenza at fin-De-Siècle Monocyte trafficking to the brain with stress and inflammation: a novel Axis of immune-to-brain communication that influences mood and behavior Lethal infection of K18-Hace2 mice infected with severe acute respiratory syndrome coronavirus Illuminating viral infections in the nervous system Tenenbaum T. Neuroinvasion and inflammation in viral central nervous system infections Activation of human monocytes after infection by human coronavirus 229e In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes Cells of human Aminopeptidase N (Cd13) transgenic mice are infected by human coronavirus-229e in vitro, but not in vivo. Virology Aminopeptidase N inhibitors and Sars Neurologic alterations due to respiratory virus infections Virus-Induced Neuronal Dysfunction and Degeneration Human coronaviruses: viral and cellular factors involved in Neuroinvasiveness and Neuropathogenesis Coronavirus infection of rat dorsal root ganglia: Ultrastructural characterization of viral replication, transfer, and the early response of satellite cells Neurotropic virus tracing suggests a membranous-coating-mediated mechanism for Transsynaptic communication The Vagus nerve is one route of Transneural invasion for Intranasally inoculated influenza a virus in mice Characteristics of a coronavirus (strain 67n) of pigs Immunofluorescence studies on the pathogenesis of Hemagglutinating encephalomyelitis virus infection in pigs after Oronasal inoculation Sars-Cov-2 Cell Entry Depends on Ace2 and Tmprss2 and Is Blocked by a Clinically Proven Protease Inhibitor Studying the Possibility of Respiratory Immunization against Tick-Borne Encephalitis. Vestn Ross Akad Med Nauk Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human Dipeptidyl peptidase 4 Vacuolating encephalitis in mice infected by human coronavirus Oc43 Human respiratory coronavirus Oc43: genetic stability and Neuroinvasion Human Coronaviruses: Respiratory Pathogens Revisited as Infectious Neuroinvasive, Neurotropic, and Neurovirulent Agents Spread of a neurotropic murine coronavirus into the Cns via the trigeminal and olfactory nerves Distribution of insulin in trigeminal nerve and brain after intranasal administration Intranasal delivery of biologics to the central nervous system The infection evidence of Sars-Cov-2 in ocular surface: a single-center cross-sectional study Long-term Neuroinflammation induced by influenza a virus infection and the impact on hippocampal neuron morphology and function Multiple neural circuits mediating airway sensations: recent advances in the neurobiology of the urge-tocough The invasion routes of Neurovirulent a/Hong Kong/483/97 (H5n1) influenza virus into the central nervous system after respiratory infection in mice Evidence of the Covid-19 virus targeting the Cns: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms Non-Neural Expression of Sars-Cov-2 Entry Genes in the Olfactory Epithelium Suggests Mechanisms Underlying Anosmia in Covid-19 Patients The effects of coronavirus on human nasal ciliated respiratory epithelium Intranasal delivery to the central nervous system: mechanisms and experimental considerations Sniffing neuropeptides: a Transnasal approach to the human brain Expression of severe acute respiratory syndrome coronavirus receptors, Ace2 and Cd209l in different organ derived microvascular endothelial cells Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target -a perspective Clinical pathology and pathogenesis of severe acute respiratory syndrome Pathological changes in masked palm civets experimentally infected by severe acute respiratory syndrome (Sars) coronavirus Lymphangiogenesis, lymphatic endothelial cells and lymphatic metastasis in head and neck cancer-a review of mechanisms Lymphatic Drainage from the Eye: A New Target for Therapy Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations The authors declare that they have no conflict of interest.